BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Diagnosis
22 results:

  • 1. ECPC-IDS: A benchmark endometrial cancer PET/CT image dataset for evaluation of semantic segmentation and detection of hypermetabolic regions.
    Tang D; Li C; Du T; Jiang H; Ma D; Ma Z; Grzegorzek M; Jiang T; Sun H
    Comput Biol Med; 2024 Mar; 171():108217. PubMed ID: 38430743
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular-Based Immunohistochemical Algorithm for uterine Leiomyosarcoma diagnosis.
    Momeni-Boroujeni A; Yousefi E; Balakrishnan R; Riviere S; Kertowidjojo E; Hensley ML; Ladanyi M; Ellenson LH; Chiang S
    Mod Pathol; 2023 Apr; 36(4):100084. PubMed ID: 36788080
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
    Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
    Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in uterine Leiomyoma versus Leiomyosarcoma.
    Machado-Lopez A; Alonso R; Lago V; Jimenez-Almazan J; Garcia M; Monleon J; Lopez S; Barcelo F; Torroba A; Ortiz S; Domingo S; Simon C; Mas A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216305
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical cancer: A Bioinformatics Analysis.
    Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic Profiling Aids Classification of Diagnostically Challenging uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
    Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
    Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparative study on the oncological prognosis of laparoscopy and laparotomy for stage IIA1 cervical squamous cell carcinoma.
    Chen C; Fang Z; Wang Q; Li W; Li P; Wang L; Kang S; Zhu B; Lin Z; Wang X; Wang L; Fan H; Bin X; Lang J; Liu P
    Eur J Surg Oncol; 2021 Feb; 47(2):346-352. PubMed ID: 32859433
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of safety and diagnostic performance for flexible hysteroscopy in 1591 outpatient cases.
    Kobayashi Y; Tsuji K; Nakamura K; Nagai S; Takahashi T; Kobayashi A; Anko M; Hirano T; Watanabe K; Matoba Y; Kunitomi H; Adachi M; Yamagami W; Tominaga E; Banno K; Aoki D
    Jpn J Clin Oncol; 2020 Sep; 50(10):1157-1161. PubMed ID: 32564088
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genomic Landscape of uterine Sarcomas Defined Through Prospective Clinical Sequencing.
    Hensley ML; Chavan SS; Solit DB; Murali R; Soslow R; Chiang S; Jungbluth AA; Bandlamudi C; Srinivasan P; Tap WD; Rosenbaum E; Taylor BS; Donoghue MTA; Hyman DM
    Clin Cancer Res; 2020 Jul; 26(14):3881-3888. PubMed ID: 32299819
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
    Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
    J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Loss of atrx/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
    Ahvenainen TV; Mäkinen NM; von Nandelstadh P; Vahteristo MEA; Pasanen AM; Bützow RC; Vahteristo PM
    Cancer; 2018 Dec; 124(24):4650-4656. PubMed ID: 30423196
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. uterine and Tubal Lavage for Earlier cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study.
    Maritschnegg E; Heitz F; Pecha N; Bouda J; Trillsch F; Grimm C; Vanderstichele A; Agreiter C; Harter P; Obermayr E; Vergote I; Zeillinger R; Speiser P
    Int J Gynecol Cancer; 2018 Nov; 28(9):1692-1698. PubMed ID: 30376484
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Characterization of Risk Factors and Timing of Venous Thromboembolism in Patients With uterine Serous Carcinoma.
    Gressel GM; Turker L; Dioun SM; McGinn AP; Nevadunsky NS
    Obstet Gynecol; 2018 Nov; 132(5):1130-1136. PubMed ID: 30303906
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
    Tsuyoshi H; Yoshida Y
    Cancer Sci; 2018 Jun; 109(6):1743-1752. PubMed ID: 29660202
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association of Mismatch Repair Mutation With Age at cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
    Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
    JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
    Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
    Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. History of uterine leiomyoma and risk of endometrial cancer in black women.
    Wise LA; Sponholtz TR; Rosenberg L; Adams-Campbell LL; Kuohung W; LaValley MP; Palmer JR
    Cancer Causes Control; 2016 Apr; 27(4):545-52. PubMed ID: 26923705
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Accuracy and false-positive rate of the cytologic diagnosis of follicular cervicitis: observations from the College of American Pathologists Pap Educational Program.
    Auger M; Khalbuss W; Nayar R; Zhao C; Wasserman P; Souers R; Thomas N; Moriarty AT
    Arch Pathol Lab Med; 2013 Jul; 137(7):907-11. PubMed ID: 23808462
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Age-specific effectiveness of the Finnish cervical cancer screening programme.
    Lönnberg S; Anttila A; Luostarinen T; Nieminen P
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1354-61. PubMed ID: 22665576
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.
    Morrell S; Taylor R; Wain G
    J Med Screen; 2005; 12(4):190-6. PubMed ID: 16417696
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.